000 | 01342 a2200397 4500 | ||
---|---|---|---|
005 | 20250511151725.0 | ||
264 | 0 | _c19761223 | |
008 | 197612s 0 0 ger d | ||
022 | _a0025-8458 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGlocke, M | |
245 | 0 | 0 |
_a[Evidence for the action of raubasine from a new formulation of Lamuran tablets]. _h[electronic resource] |
260 |
_bMedizinische Klinik _cSep 1976 |
||
300 |
_a1564-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAchlorhydria _xphysiopathology |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCarotid Artery, Internal _xphysiopathology |
650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 |
_aPulse _xdrug effects |
650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xtherapeutic use |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 | _aYohimbine |
700 | 1 | _aGrĂ¼bl, M | |
700 | 1 | _aKlein, K | |
700 | 1 | _aTeufel, W | |
773 | 0 |
_tMedizinische Klinik _gvol. 71 _gno. 38 _gp. 1564-8 |
|
999 |
_c801310 _d801310 |